Spots Global Cancer Trial Database for cin
Every month we try and update this database with for cin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2 | NCT01837693 | Precancerous Co... Neoplasms | Experimental: i... | 25 Years - 59 Years | Azienda Unità Sanitaria Locale Reggio Emilia | |
| Conservative Management of HSIL in Patients With Future Pregnancy Aspiration | NCT04783805 | Cervical Intrae... Squamous Intrae... Uterine Cervica... | Conservative ma... Conization | - | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |
| Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood | NCT06261879 | Cervical Cancer CIN | Special sanitar... | 18 Years - 65 Years | WomenX Biotech Limited | |
| Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia | NCT02692742 | Chemotherapy-In... Myelosuppressio... Breast Cancer | Myelo001 Placebo | 18 Years - | Myelo Therapeutics GmbH | |
| A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia | NCT00154089 | Cervical Intrae... | EM-1421 | 18 Years - | Erimos Pharmaceuticals | |
| A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia | NCT00154089 | Cervical Intrae... | EM-1421 | 18 Years - | Erimos Pharmaceuticals | |
| Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer | NCT00701870 | Non-small Cell ... | ezatiostat hydr... | 18 Years - | Telik | |
| Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL | NCT01928225 | Cervical High G... | Human Papilloma... | 18 Years - | University of Witwatersrand, South Africa | |
| A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China | NCT05662020 | Human Papilloma... | Recombinant Non... GARDASIL® 9 | 9 Years - 26 Years | Beijing Health Guard Biotechnology, Inc | |
| Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection | NCT03239223 | HSIL HSIL of Cervix High-Grade Squa... High-grade Cerv... Human Papilloma... Cervical Cancer Cervical Intrae... Cervical Neopla... Cervical Dyspla... CIN | ABI-1968 | 25 Years - 50 Years | Antiva Biosciences | |
| Effect of Alpha-lipoic Acid on Regression of Low-grade Squamous Intraepithelial Lesions (LSIL) | NCT05485259 | Low-Grade Squam... | DL-alpha lipoic... placebo (rice s... | 18 Years - 55 Years | University of Zagreb | |
| Cervical Cancer Early Endpoints and Determinants | NCT00339989 | Cervical Cancer Cervical Intrae... Neoplasia CIN | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer | NCT00701870 | Non-small Cell ... | ezatiostat hydr... | 18 Years - | Telik | |
| A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine | NCT05694728 | Human Papilloma... | Recombinant Non... Recombinant Qua... | 20 Years - 45 Years | Beijing Health Guard Biotechnology, Inc | |
| Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL | NCT01928225 | Cervical High G... | Human Papilloma... | 18 Years - | University of Witwatersrand, South Africa | |
| Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix | NCT02206048 | Cervix Carcinom... | Proflavine High-Resolution... | 21 Years - 64 Years | M.D. Anderson Cancer Center | |
| Cervical Cancer Early Endpoints and Determinants | NCT00339989 | Cervical Cancer Cervical Intrae... Neoplasia CIN | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine | NCT06261892 | Cervical Cancer | Collect HPV DNA... | 18 Years - 65 Years | WomenX Biotech Limited | |
| IMproved PRactice Outcomes and Value Excellence in Colposcopy | NCT02185599 | High Grade Cerv... | DySIS | 21 Years - | DySIS Medical Inc. | |
| New Gentle Biopsy Method of Cervix Lesions Using Superficial Curettage/Protocol ID: CX-CUR | NCT01836588 | CIN Cervical Cancer | conventional ce... | 18 Years - 80 Years | Charite University, Berlin, Germany | |
| A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine | NCT05694728 | Human Papilloma... | Recombinant Non... Recombinant Qua... | 20 Years - 45 Years | Beijing Health Guard Biotechnology, Inc | |
| Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 | NCT05580341 | Cervical Cancer Genital Wart CIN VIN Papillomavirus ... | Zerun HPV-9 GARDASIL ®9 | 16 Years - 26 Years | Shanghai Zerun Biotechnology Co.,Ltd | |
| Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL | NCT01928225 | Cervical High G... | Human Papilloma... | 18 Years - | University of Witwatersrand, South Africa | |
| A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine | NCT05680454 | Human Papilloma... | Recombinant Non... Recombinant non... | 18 Years - 45 Years | Beijing Health Guard Biotechnology, Inc | |
| A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia | NCT00154089 | Cervical Intrae... | EM-1421 | 18 Years - | Erimos Pharmaceuticals | |
| UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis. | NCT05043662 | Urothelial Carc... Diagnoses Disea... Ureter Cancer IMAGE Cytology | UroCAD assay, C... | 18 Years - | Changhai Hospital | |
| Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy | NCT04809727 | CIN Cancer of Cervi... Cervicitis | Cervical biopsy | 40 Years - | Tanta University | |
| Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia | NCT02692742 | Chemotherapy-In... Myelosuppressio... Breast Cancer | Myelo001 Placebo | 18 Years - | Myelo Therapeutics GmbH |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
